Purchase Order 75N94024P00502

The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation.

Polypeptide Labs is a specialized manufacturer of peptides and related compounds, primarily providing synthesis, distribution, and testing services to support biomedical research efforts of various NIH agencies. The company currently holds two significant Indefinite Delivery Contracts (IDCs) with NIH agencies: a $49,713,679 single-award IDC with the National Center for Advancing Translational Sciences (NCATS) for chemistry, manufacturing, and controls (CMC) services, and a $2,781,317 IDC with the National Institute on Drug Abuse (NIDA) for the synthesis and distribution of opioid and related peptides. This latest purchase order from NICHD further demonstrates Polypeptide Labs' critical role in supporting NIH's research initiatives across multiple institutes, particularly in the areas of drug development and substance abuse research.